We also observed that the levels of pTau T181 exhibited a strong trend toward reduction after Cdk5i-FT peptide treatment ( Fig. 2 M and N ).
← all excerpts
A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes.
1
—
—